2008
DOI: 10.1111/j.1463-1318.2007.01448.x
|View full text |Cite
|
Sign up to set email alerts
|

Transanal endoscopic microsurgery in early rectal cancer: time for a trial?

Abstract: Significant heterogeneity limits conclusions from current literature. A trial is required. Alternate end-points to local recurrence may be required in assessing the optimal surgical approach, which balances disease control with quality of life, and probability of noncancer related death.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
43
0
7

Year Published

2009
2009
2019
2019

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 66 publications
(54 citation statements)
references
References 59 publications
(75 reference statements)
4
43
0
7
Order By: Relevance
“…The role of TEM in the treatment of adenocarcinoma is controversial. [13][14][15][16][17] Generally, TEM has been used for adenomas not amenable to endoscopic or transanal excision, for T1N0 rectal carcinomas in patients who accept a higher risk of local recurrence to avoid radical rectal resection, and for palliative resection for more advanced lesions in medically unfit patients.…”
Section: Discussionmentioning
confidence: 99%
“…The role of TEM in the treatment of adenocarcinoma is controversial. [13][14][15][16][17] Generally, TEM has been used for adenomas not amenable to endoscopic or transanal excision, for T1N0 rectal carcinomas in patients who accept a higher risk of local recurrence to avoid radical rectal resection, and for palliative resection for more advanced lesions in medically unfit patients.…”
Section: Discussionmentioning
confidence: 99%
“…A full-thickness LE can be proposed as a curative surgical procedure only for the treatment of adenomas and selected T1 rectal cancers [81,82]. There is increasing evidence that this approach can be offered also to patients with intraperitoneal rectal cancers, with no increased morbidity and cancer-related mortality [83][84][85][86][87][88].…”
Section: Qualitative Risk Factors and New Biomarkersmentioning
confidence: 99%
“…The depth of submucosal invasion represents one of the most important risk factors for local recurrence and poor survival in patients undergoing LE for ERC [5,77,78,81,82,97,98,100]. One of the main limitations of the preoperative staging is the identification of T1 sm1 rectal cancers [106][107][108].…”
Section: Qualitative Risk Factors and New Biomarkersmentioning
confidence: 99%
“…Probablemente el hecho que el diseño y longitud del dispositivo le ha permitido ajustarse de forma ideal al canal anal, no ocasionando mayor trauma y a diferencia del TEM (en los que sí existen series que describen alteraciones funcionales post-procedimiento), TAMIS no se ha asociado a incontinencia anal a corto plazo 18 . Las tasas de complicaciones tras la cirugía transanal han sido bien documentadas y promedian un 4% en series retrospectivas 14,19,[20][21] . Dentro de ellas, la hemorragia, la dehiscencia de la línea de sutura, formación de abscesos, incontinencia anal esporádica y la estenosis son las más comunes.…”
Section: Discussionunclassified